Phase I study of paclitaxel in combination with cyclophosphamide and granulocyte colony-stimulating factor in metastatic breast cancer patients. [electronic resource]
Producer: 19960223Description: 95-102 p. digitalISSN:- 0732-183X
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Blood Cell Count -- drug effects
- Breast Neoplasms -- pathology
- Cyclophosphamide -- administration & dosage
- Diarrhea -- chemically induced
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Drug Hypersensitivity -- drug therapy
- Equipment Failure
- Erythrocyte Transfusion
- Female
- Granulocyte Colony-Stimulating Factor -- administration & dosage
- Hematologic Diseases -- blood
- Hematuria -- chemically induced
- Home Infusion Therapy -- instrumentation
- Humans
- Mesna -- therapeutic use
- Middle Aged
- Neoplasm Metastasis
- Paclitaxel -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article
There are no comments on this title.
Log in to your account to post a comment.